ATE358476T1 - L-acetylcarnitine als antitumormittel - Google Patents
L-acetylcarnitine als antitumormittelInfo
- Publication number
- ATE358476T1 ATE358476T1 AT99947427T AT99947427T ATE358476T1 AT E358476 T1 ATE358476 T1 AT E358476T1 AT 99947427 T AT99947427 T AT 99947427T AT 99947427 T AT99947427 T AT 99947427T AT E358476 T1 ATE358476 T1 AT E358476T1
- Authority
- AT
- Austria
- Prior art keywords
- acetylcarnitine
- antitumor agent
- somatosstatin
- acylcarnitines
- found
- Prior art date
Links
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title abstract 2
- 229960001009 acetylcarnitine Drugs 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002090A IT1302289B1 (it) | 1998-09-30 | 1998-09-30 | Composizioni farmaceutiche ad attivita' antineoplastica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358476T1 true ATE358476T1 (de) | 2007-04-15 |
Family
ID=11380776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99947427T ATE358476T1 (de) | 1998-09-30 | 1999-09-27 | L-acetylcarnitine als antitumormittel |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6673839B1 (de) |
| EP (1) | EP1117393B1 (de) |
| JP (1) | JP2002525316A (de) |
| AT (1) | ATE358476T1 (de) |
| AU (1) | AU761357B2 (de) |
| CA (1) | CA2345724C (de) |
| DE (1) | DE69935724T2 (de) |
| DK (1) | DK1117393T3 (de) |
| ES (1) | ES2284267T3 (de) |
| IL (1) | IL142295A (de) |
| IS (1) | IS5902A (de) |
| IT (1) | IT1302289B1 (de) |
| NO (1) | NO20011578L (de) |
| NZ (1) | NZ510803A (de) |
| WO (1) | WO2000018385A2 (de) |
| ZA (1) | ZA200102545B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006347935A (ja) * | 2005-06-15 | 2006-12-28 | Masanori Ogata | 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬 |
| CA2681185C (en) * | 2007-03-21 | 2018-05-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| MX2011005593A (es) * | 2008-12-01 | 2011-06-20 | Sigma Tau Ind Farmaceuti | Uso de alcanoil l-carnitina en combinacion con agentes quimioterapeuticos para el tratamiento de neoplasmas. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05339148A (ja) * | 1992-05-28 | 1993-12-21 | T Knight Albert | 血液脳関門を通過する物質 |
| US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
| IT1277898B1 (it) * | 1995-08-03 | 1997-11-12 | Mendes Srl | Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie |
| WO1997006788A1 (en) * | 1995-08-14 | 1997-02-27 | Janssen Pharmaceutica N.V. | Transdermal administration of vorozole |
| JPH11292787A (ja) | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | 生理活性ペプチドを含有する経粘膜投与製剤 |
| IT1283951B1 (it) | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
| PT1100589E (pt) * | 1998-07-30 | 2005-05-31 | Sigma Tau Ind Farmaceuti | Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena |
-
1998
- 1998-09-30 IT IT1998MI002090A patent/IT1302289B1/it active IP Right Grant
-
1999
- 1999-09-27 EP EP99947427A patent/EP1117393B1/de not_active Expired - Lifetime
- 1999-09-27 IL IL14229599A patent/IL142295A/en not_active IP Right Cessation
- 1999-09-27 JP JP2000571904A patent/JP2002525316A/ja active Pending
- 1999-09-27 AU AU60877/99A patent/AU761357B2/en not_active Ceased
- 1999-09-27 CA CA002345724A patent/CA2345724C/en not_active Expired - Fee Related
- 1999-09-27 WO PCT/EP1999/007170 patent/WO2000018385A2/en not_active Ceased
- 1999-09-27 ES ES99947427T patent/ES2284267T3/es not_active Expired - Lifetime
- 1999-09-27 DK DK99947427T patent/DK1117393T3/da active
- 1999-09-27 AT AT99947427T patent/ATE358476T1/de not_active IP Right Cessation
- 1999-09-27 NZ NZ510803A patent/NZ510803A/en not_active IP Right Cessation
- 1999-09-27 DE DE69935724T patent/DE69935724T2/de not_active Expired - Lifetime
- 1999-09-27 US US09/806,153 patent/US6673839B1/en not_active Expired - Fee Related
-
2001
- 2001-03-20 IS IS5902A patent/IS5902A/is unknown
- 2001-03-28 ZA ZA200102545A patent/ZA200102545B/en unknown
- 2001-03-28 NO NO20011578A patent/NO20011578L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20011578L (no) | 2001-05-30 |
| DK1117393T3 (da) | 2007-08-06 |
| ZA200102545B (en) | 2001-09-28 |
| EP1117393B1 (de) | 2007-04-04 |
| ES2284267T3 (es) | 2007-11-01 |
| WO2000018385A2 (en) | 2000-04-06 |
| JP2002525316A (ja) | 2002-08-13 |
| ITMI982090A1 (it) | 2000-03-30 |
| IS5902A (is) | 2001-03-20 |
| NZ510803A (en) | 2003-08-29 |
| CA2345724C (en) | 2009-05-19 |
| US6673839B1 (en) | 2004-01-06 |
| WO2000018385A3 (en) | 2000-05-25 |
| CA2345724A1 (en) | 2000-04-06 |
| IL142295A (en) | 2004-08-31 |
| DE69935724T2 (de) | 2007-12-27 |
| AU6087799A (en) | 2000-04-17 |
| DE69935724D1 (en) | 2007-05-16 |
| AU761357B2 (en) | 2003-06-05 |
| NO20011578D0 (no) | 2001-03-28 |
| IL142295A0 (en) | 2002-03-10 |
| EP1117393A2 (de) | 2001-07-25 |
| IT1302289B1 (it) | 2000-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60321333D1 (de) | Tetrahydropyranyl-cyclopentyl-tetrahydropyridopyridin-modulatoren der chemokin-rezeptor-aktivität | |
| IL148903A0 (en) | Certain alkylene diamine-substituted heterocycles | |
| MXPA03011197A (es) | Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales. | |
| DK1309592T3 (da) | Substituerede pyrazoler | |
| EA200100731A1 (ru) | Фенилфенантридины с ингибирующей фдэ-4 активностью | |
| PA8527001A1 (es) | Poliarilcarboxamidas utiles como agentes reductores de lipidos | |
| ATE271041T1 (de) | Analoga von duocarmycin and cc-1065 | |
| DK1297013T3 (da) | Anvendelse af TACI som antitumormiddel | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| BRPI0414599A (pt) | pirrol-indóis substituìdos | |
| ATE375978T1 (de) | Benzoylsulfonamide als antitumor-mittel | |
| BR0115139A (pt) | Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante | |
| DE69708340D1 (de) | Arylsulfonylimidazolon-derivate als antitumormittel | |
| EA200300988A1 (ru) | Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина | |
| ATE372330T1 (de) | N-sulfonylurea-apoptosis-förderer | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| DE69935724D1 (en) | L-acetylcarnitine als antitumormittel | |
| DK1244643T3 (da) | Tryptaseinhibitorer | |
| ATE268322T1 (de) | Inhibitoren der tryptase | |
| MX9304152A (es) | Inhibidores de enzimas. | |
| DK1144423T3 (da) | Bis-terpyridin-platin(II)-komplekser | |
| IT1271689B (it) | 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono | |
| SE9803107D0 (sv) | Novel Compunds | |
| ATE222103T1 (de) | Inklusionskomplexe in waessriger loesung | |
| ATE350025T1 (de) | Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1117393 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |